Alexander C Egbe1, William R Miranda2, Joseph Dearani3, Patrick S Kamath4, Heidi M Connolly2. 1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: egbe.alexander@mayo.edu. 2. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. 3. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
BACKGROUND: Hepatorenal dysfunction is a risk factor for mortality in patients with chronic tricuspid regurgitation due to acquired heart disease. Ebstein anomaly is the most common cause of primary tricuspid regurgitation in adults with congenital heart disease, but the prevalence and prognostic implications of hepatorenal dysfunction are unknown in this population. OBJECTIVES: The purpose of this study was to determine the risk factors and prognostic implications of hepatorenal dysfunction, as measured primarily by the use of model for end-stage liver disease excluding international normalized ratio (MELD-XI score), as well as looking at other associated factors. METHODS: This was a retrospective study of adults with Ebstein anomaly who received care at Mayo Clinic from 2003 to 2018. RESULTS: Of 692 patients, the median MELD-XI score was 10.2 (interquartile range: 9.4 to 13.3); 53 (8%) died and 3 (0.4%) underwent heart transplant. MELD-XI was an independent predictor of death/transplant (hazard ratio: 1.32; 95% confidence interval: 1.11 to 2.06; p < 0.001). In the subset of patients with serial MELD-XI scores (n = 416), temporal change in MELD-XI score (ΔMELD-XI) was also a predictor of death/transplant. In the subset of patients who underwent tricuspid valve surgery (n = 344), a post-operative improvement in MELD-XI score (ΔMELD-XI) was associated with improved long-term survival. Impaired right atrial (RA) reservoir strain and elevated estimated RA pressure were associated with worse baseline MELD-XI and ΔMELD-XI scores. CONCLUSIONS: Hepatorenal dysfunction is a predictor of mortality in Ebstein anomaly, and RA dysfunction and hypertension are hemodynamic biomarkers that can identify patients at risk for deterioration in hepatorenal function and mortality. These data highlight the prognostic importance of noncardiac organ-system dysfunction, and provide complementary clinical risk stratification metrics for management of these patients.
BACKGROUND: Hepatorenal dysfunction is a risk factor for mortality in patients with chronic tricuspid regurgitation due to acquired heart disease. Ebstein anomaly is the most common cause of primary tricuspid regurgitation in adults with congenital heart disease, but the prevalence and prognostic implications of hepatorenal dysfunction are unknown in this population. OBJECTIVES: The purpose of this study was to determine the risk factors and prognostic implications of hepatorenal dysfunction, as measured primarily by the use of model for end-stage liver disease excluding international normalized ratio (MELD-XI score), as well as looking at other associated factors. METHODS: This was a retrospective study of adults with Ebstein anomaly who received care at Mayo Clinic from 2003 to 2018. RESULTS: Of 692 patients, the median MELD-XI score was 10.2 (interquartile range: 9.4 to 13.3); 53 (8%) died and 3 (0.4%) underwent heart transplant. MELD-XI was an independent predictor of death/transplant (hazard ratio: 1.32; 95% confidence interval: 1.11 to 2.06; p < 0.001). In the subset of patients with serial MELD-XI scores (n = 416), temporal change in MELD-XI score (ΔMELD-XI) was also a predictor of death/transplant. In the subset of patients who underwent tricuspid valve surgery (n = 344), a post-operative improvement in MELD-XI score (ΔMELD-XI) was associated with improved long-term survival. Impaired right atrial (RA) reservoir strain and elevated estimated RA pressure were associated with worse baseline MELD-XI and ΔMELD-XI scores. CONCLUSIONS: Hepatorenal dysfunction is a predictor of mortality in Ebstein anomaly, and RA dysfunction and hypertension are hemodynamic biomarkers that can identify patients at risk for deterioration in hepatorenal function and mortality. These data highlight the prognostic importance of noncardiac organ-system dysfunction, and provide complementary clinical risk stratification metrics for management of these patients.
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Tao Fujioka; Andreas Kühn; Sergio Sanchez-Martinez; Bart H Bijnens; Wei Hui; Cameron Slorach; Christoph Roehlig; Luc Mertens; Manfred Vogt; Mark K Friedberg Journal: JACC Cardiovasc Imaging Date: 2018-12-12
Authors: Yohei Akazawa; Tao Fujioka; Andreas Kühn; Wei Hui; Cameron Slorach; Christoph Roehlig; Luc Mertens; Manfred Vogt; Mark K Friedberg Journal: Can J Cardiol Date: 2019-06-12 Impact factor: 5.223
Authors: Gabriele Egidy Assenza; Dionne A Graham; Michael J Landzberg; Anne Marie Valente; Michael N Singh; Aamir Bashir; Susan Fernandes; Koenraad J Mortele; Chinweike Ukomadu; Massimo Volpe; Fred Wu Journal: Heart Date: 2013-02-13 Impact factor: 5.994
Authors: Margaret S Kim; Tomoko S Kato; Maryjane Farr; Christina Wu; Raymond C Givens; Ellias Collado; Donna M Mancini; P Christian Schulze Journal: J Am Coll Cardiol Date: 2013-04-03 Impact factor: 24.094
Authors: Larry A Allen; G Michael Felker; Stuart Pocock; John J V McMurray; Marc A Pfeffer; Karl Swedberg; Duolao Wang; Salim Yusuf; Eric L Michelson; Christopher B Granger Journal: Eur J Heart Fail Date: 2009-02 Impact factor: 15.534
Authors: Alexander C Egbe; Heidi M Connolly; Patricia A Pellikka; Jason H Anderson; William R Miranda Journal: Circ Cardiovasc Imaging Date: 2022-09-20 Impact factor: 8.589